Overview
Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)
Status:
Completed
Completed
Trial end date:
2000-05-01
2000-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study will evaluate the ability of montelukast to improve the signs and symptoms of seasonal allergic rhinitis compared with loratadine and placebo.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Loratadine
Montelukast
Criteria
Inclusion Criteria:- Patient has a documented history of seasonal allergic rhinitis symptoms that flare up
during the study season
- Patient is a nonsmoker and has been a nonsmoker for at least 1 year
- Patient is in good general health
Exclusion Criteria:
- Patient is hospitalized
- Patient is a woman who is less than 8 weeks postpartum or is breast-feeding
- Patient intends to move or vacation away during the study
- Patient has had any major surgery within 4 weeks of study start
- Patient is a current or past abuser of alcohol or illicit drugs
- Patient has been treated in an emergency room for asthma in the past month
- Patient had an upper respiratory infection with in 3 weeks prior to study start